Applications of 2-(Hydroxyimino)-1-((4-Methylphenyl)Sulfonyl)Eth-2-Ylamine in Industrial Manufacturing

Our factory-direct supply of 2-(Hydroxyimino)-1-((4-Methylphenyl)Sulfonyl)Eth-2-Ylamine serves demanding industrial customers in synthesis-driven segments. Using advanced production and quality control processes, we supply consistent, specification-driven raw material suitable for regulated applications. Below, we detail the principal downstream sectors that utilize this intermediate, with specific information on technical standards, proportioning, process placement, and final product categories to support informed B2B decisions and support technical validation.

1. API (Active Pharmaceutical Ingredient) Synthesis: Antibacterial Drug Precursors

This compound supports select pharmaceutical manufacturing processes as a reactive intermediate in the synthesis of several next-generation antibacterial agents, particularly within the cephalosporin and carbacephem antibiotic classes. Its oxime and sulfonylamide functionalities enable regioselective transformations after acylation or cyclization, facilitating side-chain construction and targeted activity. Our customers require validated lot consistency and traceability for global submission batches, aligning with international pharmaceutical supply chain expectations.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP, Ph. Eur., JP (applicable based on drug registration region)
• 21 CFR Part 211 (US FDA cGMP for finished pharmaceuticals)
• EMA Guideline on the Chemistry of Active Substances

Typical usage ratio

• 0.8% – 2.4% by mass in the key intermediate coupling stage, adjusted by molar equivalents based on the side-chain formation reaction yield and impurity profile management

Downstream process integration

• Charged after the initial β-lactam backbone activation for side-chain attachment, under controlled anhydrous conditions, followed by monitoring with HPLC and MS traceability for each batch

Final product types

• Antibacterial API intermediates (e.g., ceftibuten, cefdinir)
• Bulk antibiotics for formulation into parenteral or oral finished dosage forms
• Pharmaceutical substances for regulatory submissions and secondary manufacture

2. Agrochemical Synthesis: Herbicide Intermediate

Within crop protection chemical production, this compound acts as a key building block for certain sulfonylurea and pyrimidinyl sulfonyl derivatives, supporting high-selectivity, low-residue herbicide formulations. Agrochemical manufacturers use the oxime group for subsequent condensation or rearrangement reactions to introduce highly specific binding motifs into the final actives for pre- or post-emergence weed control. Product stewardship includes alignment with region-specific agricultural chemical safety standards.

Industry compliance standards

• FAO/WHO Joint Meeting on Pesticide Specifications (JMPS)
• REACH (EU Regulation EC 1907/2006)
• China ICAMA active ingredient certification for domestic and export sales
• OECD Principles of Good Laboratory Practice (GLP) for registration purposes

Typical usage ratio

• 1.5% – 3.2% by weight in conjugation or cyclization steps, with the exact proportion determined by the downstream molecular architecture and waste minimization protocols in the target synthesis route

Downstream process integration

• Incorporated during the late-stage nucleophilic substitution or rearrangement, typically under basic or phase-transfer catalyzed conditions; reacted under strict temperature and process time controls to maximize selectivity

Final product types

• Sulfonylurea herbicide actives (e.g., metsulfuron-methyl, sulfosulfuron derivatives)
• Formulated herbicide granules or water-dispersible powders
• Technical concentrates for further downstream blending

3. Specialty Dye and Pigment Intermediates for High-Fastness Applications

Manufacturers of specialty dyes harness this molecule in the custom synthesis of azo and sulfur dyes, designed for technically demanding textile, oxidative hair dye, or industrial markers. Its structure lends selective reactivity with aromatic diazonium salts and couplers, enabling unique chromophores and high-affinity sulfonyl linkages for improved wash and lightfastness. Finished pigment preparations built upon these intermediates must withstand robust textile processing and industrial laundering protocols.

Industry compliance standards

• OEKO-TEX® Standard 100 for restricted substances in textiles
• REACH Annex XVII Restrictions (EU chemicals regulation)
• ZDHC MRSL (Zero Discharge of Hazardous Chemicals Manufacturing Restricted Substances List)
• ISO 105 series for colorfastness testing methods

Typical usage ratio

• 1.0% – 2.7% in the coupling or diazo stage, modulated by target pigment loading, downstream bath chemistry, and performance testing in simulated end-use conditions

Downstream process integration

• Modeled for use in the advanced stage of diazotization or after initial coupling; added with real-time pH, temperature, and total solids monitoring to ensure desired substitution and crystallinity in pigment matrices

Final product types

• Washfast direct dyes for cellulosic fibers
• High-purity textile sulfur dyes
• Industrial marking pigments and functional colorants

4. Photographic and Imaging Chemical Precursors

This molecule is specified in the formulation of key precursors for color photographic developer, coupler, and image-stabilizing systems. Its role is especially prominent in the production of imagewise color couplers and fog inhibitors used during emulsion finishing stages, contributing to grain sharpness and anti-fading performance in film and digital photographic media. Rigorous QC ensures absence of trace contaminants that could affect imaging precision or archival stability during high-speed coating operations.

Industry compliance standards

• ISO 18902: Imaging materials – Processed imaging materials – Albumen, collodion, and gelatin silver prints – Storage practices
• ANSI/NAPM IT9.2: Photographic film – ISO speed testing
• ISO 9001 Quality Management Systems certification for chemical intermediates production
• RoHS compliance (for absence of restricted metals or persistent toxins)

Typical usage ratio

• 0.6% – 1.9% relative to other image coupler feedstocks in developer or image-stabilizer batches, calibrated by test coating yield and densitometry data from in-process emulsion evaluation

Downstream process integration

• Fed into emulsion or color-coupler mixing tanks during the controlled temperature processing phase, with close solvent handling and in-line spectrophotometric purity monitoring before film or paper substrate application

Final product types

• Color-developing agents for silver halide film
• Image stabilizer components for professional and archival photographic papers
• Imaging-grade emulsion additives for inkjet and laser printing base media

5. Fine Chemical Synthesis: Protective Group Applications

Producers of peptide and nucleoside synthesis intermediates employ this raw material as a selective oxime protecting and activating group for sensitive amines and aldehydes. Its distinct sulfonyl group not only steers reactivity for orthogonal protection but also allows for mild deprotection compatible with multi-step small molecule synthesis. Customers in this segment require documentation for trace impurities and batch-specific residual solvent content to maintain reproducibility and downstream process safety.

Industry compliance standards

• IPEC-PQG Joint Good Manufacturing Practices Guide for Pharmaceutical Excipients
• Ph. Eur. (specific monographs as required for protected intermediates)
• ISO 9001:2015 for specialty chemical manufacturing
• Responsible Care Global Charter for environmental and product stewardship

Typical usage ratio

• 0.5% – 1.1% on molar basis for the targeted residue introduction, adjusted by substrate reactivity and removal strategy

Downstream process integration

• Utilized in early-stage protection steps during solid-phase or solution-phase synthesis, introduced before high-temperature condensation or acid-sensitive transformations, followed by process-specific deprotection protocols

Final product types

• Masked peptide intermediates for injectable and oral therapeutic candidates
• Protected nucleoside analogs for oligonucleotide drug API development
• Ready-to-use fine chemical building blocks for advanced chemical synthesis services